Author

S. Eto

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

R. Nishimura· 2 shared T. Nakagawa· 2 shared A. Eguchi· 1 shared A. Iio· 1 shared H. Sugiya· 1 shared K. Kaji· 1 shared K. Saeki· 1 shared K. Suzuki· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

R. Nishimura

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Subchronic Toxicity Assessment of Perfluoroalkyl Substances by Mixed Exposure of Nine Substances at Daily Intake Relevant Concentration

K. Takeda, T. Saito, S. Sasaki, A. Eguchi, M. Sugiyama, K. Suzuki, S. Eto, R. Kamata

This study assesses the subchronic toxicity of a PFAS mixture in mice, finding liver morphological changes and alterations in metabolism and cancer-related gene expression.

bioRxiv · May 17, 2023 · PreprintPharmacology & Toxicology

CCR4 blockade leads to clinical activity and prolongs survival in a canine model of advanced prostate cancer

S. Maeda, T. Motegi, A. Iio, K. Kaji, Y. Goto-Koshino, S. Eto, N. Ikeda, T. Nakagawa, R. Nishimura, T. Yonezawa, Y. Momoi

The paper shows that blocking CCR4 reduces Treg infiltration and improves survival in a canine model of advanced prostate cancer.

bioRxiv · Apr 12, 2021 · PreprintCancer Biology

Aberrant expression of the COX2/PGE2 axis is induced by activation of the RAF/MEK/ERK pathway in BRAFV595E canine urothelial carcinoma

R. Yoshitake, K. Saeki, S. Eto, M. Shinada, R. Nakano, H. Sugiya, Y. Endo, N. Fujita, R. Nishimura, T. Nakagawa

This study shows that BRAF mutation activates the RAF/MEK/ERK pathway, leading to COX2 overexpression and PGE2 production in canine urothelial carcinoma, promoting inflammation.

bioRxiv · Oct 1, 2019Cancer Biology